Mayo Clinic Platform_Accelerate has announced a strategic agreement with the Japan External Trade Organization (JETRO) to implement a two-phase program aimed at enhancing U.S. healthcare and business immersion opportunities for Japanese health technology companies.

A generous $20 million gift from Dwight and Dian Diercks will fuel key elements of Mayo Clinic’s vision for the future of healthcare, including Mayo Clinic Platform and the application of artificial intelligence (AI) for early detection and intervention in cancer.

More than 250 global leaders in technology and healthcare gathered June 4-5 in Phoenix for PlatforMed 2024. Healthcare leaders, industry experts, policymakers, investors, and startups shared new insights and discussed the future of healthcare.

Mayo Clinic and Mercy are making a significant advancement in their global, first-of-its-kind 10-year collaboration agreement signed in the summer of 2022. As founding members of Mayo Clinic Platform_Connect, the two organizations will now be working together to analyze de-identified patient data as they search for new ways to diagnose, treat and prevent disease, providing better outcomes and lower costs of care.

The first-of-its-kind alliance moves into new regions to transform global healthcare and improve access, diagnostics and treatments for patients everywhere.

Mayo Clinic Platform_Accelerate celebrated the graduation of its fourth cohort of health tech startups, including nine innovative businesses from around the world. During the graduation event, held March 28 in Eagan, Minnesota, each company presented progress and outcomes from the 20-week accelerator program, providing a glimpse into the future of medicine.

Mayo Clinic Platform launches Solutions Studio, a new program that accelerates the development, validation and deployment of digital health solutions and integrates them into healthcare workflows. The Solutions Studio program will alleviate the high costs and complexities that digital health companies face in the commercialization process and will streamline the adoption of solutions in hospitals.

Mayo Clinic Platform_Accelerate celebrated the graduation of its third cohort of health tech startups, including 12 national and international innovative businesses.

Innovative data science will enable scalable and accessible personalized, predictive and proactive medicine for patients

With the recent launch of a product to evaluate artificial intelligence (AI) models for accuracy and susceptibility to bias, Mayo Clinic Platform is accelerating adoption of data-driven innovation in clinical practice.

Mayo Clinic Platform_Accelerate has announced its second cohort of health tech startups, including national and international businesses. The program will help seven companies develop and validate their artificial intelligence-driven health care products or solutions and advance their business plans.

This collaboration will create an environment that enables rapid product development in the U.S. and Israeli markets, allowing technologies to be established and launched to transform health care delivery for all.